🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to describe the nicotine pharmacokinetic (PK)...
Status
Completed
Location
Celerion
Start Date
2023-02-16
Trial ID
NCT05789420
This is a single-center, open-label, parallel-cohort study to measure and c...
Status
Completed
Location
Clinical Research Atlanta
Start Date
2022-05-23
Trial ID
NCT05363254
This is a randomised, cross-over, open-label, confinement study conducted i...
Status
Completed
Location
Celerion
Start Date
2023-07-07
Trial ID
NCT06093659
Treatments Being Tested
This study investigates the feasibility, acceptability, and short-term effe...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2024-09-23
Trial ID
NCT06472869
Treatments Being Tested
This is a randomized, open-label, 6-way crossover, multi-site study designe...
Status
Completed
Location
QPS Bio-Kinetic
Start Date
2022-03-21
Trial ID
NCT05210699
Vaping is increasingly popular with both adolescent and adult Canadians, bu...
Status
Recruiting
Location
University of Alberta (Clinical Sciences Building)
Start Date
2025-07-25
Trial ID
NCT06819969
This is a two-site, open-label, randomized, 4-way (2 arm) cross-over study ...
Status
Recruiting
Location
Dr. Vince Clinical Research
Start Date
2025-12-15
Trial ID
NCT07132814
The purpose of this study is to assess changes in exposure to selected harm...
Status
Completed
Location
Celerion
Start Date
2019-03-01
Trial ID
NCT04019626
This three-group randomized double-blind placebo-controlled trial (N=180) w...
Status
Completed
Location
Rose Research Center
Start Date
2021-12-14
Trial ID
NCT05205811
Treatments Being Tested
The present project will evaluate the initial efficacy of approach bias ret...
Status
Completed
Location
RESTORE Laboratory
Start Date
2022-10-03
Trial ID
NCT05306158
Treatments Being Tested